Bigwig US grocer Wal-Mart Stores Inc. has revealed in a Tuesday announcement that it has efforts underway to phase out the sale of eggs from caged hens, at US Wal-Mart and Sam's Club stores, by the year 2025.
The announcement underscores Wal-Mart's commitment to supply 100% cage-free eggs by the mentioned timeline.
The announcement made by Wal-Mart makes it the biggest and most prominent food retail chain to set a deadline for switching to cage-free eggs; especially after some other big grocery stores -- including Albertsons, Kroger, and Supervalu -- have also announced similar commitments of late.
The decision by leading grocers to completely transition to a 100% cage-free egg supply by 2025 scores a highly noteworthy win for individuals and organizations supporting animal rights and sustainability.
Asserting that the 2025 goal for transitioning to 100% cage-free egg supply is based on "available supply, affordability and customer demand," Wal-Mart's chief sustainability officer Kathleen McLaughlin said: "Our commitment to transition to a cage-free egg supply chain recognizes that expectation and represents another step we are taking to improve transparency for food we sell in our US stores and clubs."
In a recently released official website statement, Sony has announced that Sony Computer Entertainment (SCE) has been renamed as Sony Interactive Entertainment (SCE).
Announcing the official change made to the corporate name of SCE, Sony...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
On Tuesday, the US Federal Trade Commission (FTC) filed a complaint in federal court, accusing German automaker Volkswagen (VW) of repeatedly making false claims in its 'Clean Diesel' ads.
Asserting that the claims made by VW in its 'Clean...
Rapid increase in private consumption by domestic consumers helped the Germany's economy to grow...
Music streaming service Spotify has efforts underway to migrate most of its home-built...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
According to reports, the Egyptian government has...
On Thursday, March 31, the Federal Communications...
Against the backdrop of the now-vacated San Bernardino...
On Tuesday, the US Federal Trade Commission (FTC) filed...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).